Affecting an estimated 3-10% of the population, seborrheic dermatitis is a chronic non-contagious skin condition, but treatment options remain limited in their efficacy, as compared to management protocols for other inflammatory skin diagnoses. 

Limited Research on Seborrheic Dermatitis

Presenting as scaly or inflamed patches of skin causing dandruff-like flakes, seborrheic dermatitis (SD) commonly affects oily areas of the body, such as the scalp line, side of the nose, ears, chin, and chest. The exact pathology of the condition is uncertain, but doctors agree that excessive sebum (oil) production, an immune system vulnerability, or the presence of a particular fungus may create the right conditions for a flareup. Other risk factors include fatigue, stress, mental health issues, immune system disorders, or even seasonal changes. What complicates this common condition is that the presentation of SD symptoms varies widely across different demographics, patient profiles, and environmental contexts, making it difficult to achieve diagnostic consistency. 

A recent review published in the Journal of the American Academy of Dermatology analyzed the pathophysiology, risk factors, presentation, diagnosis, and available treatment options for seborrheic dermatitis. However, the study acknowledged that physicians need to improve their recognition of patient-specific manifestations of seborrheic dermatitis and familiarize themselves with presentation varieties in different skin types. Furthermore, treatment options are directed at minimizing the presence of Malassezia spp., and thus mitigating the inflammatory response by the body, which is often achieved through the use corticosteroids.  

Corticosteroids should only be used for limited periods, and patients using other treatment options have reported unwanted side effects. The use of nonsteroidal PDE-4 inhibitors is promoted by the JAAD review, as it demonstrated strong efficacy in improving SD symptoms on various parts of the body with limited side effects. Other novel treatments for seborrheic dermatitis are still being explored. 

Hyaluronic Acid for Seborrheic Dermatitis

Given the symptoms and causes of seborrheic dermatitis, various studies have focused on the efficacy of hyaluronic acid for the condition. Research published in the Journal of Clinical and Experimental Dermatology found that low-molecular weight hyaluronic acid was an effective and safe treatment option for seborrheic dermatitis, with a 100% improvement rate in the study subjects. While the study size was relatively small, the significant results suggest hyaluronic acid as a viable treatment option for SD and other inflammatory skin conditions. 

Hyaluronic acid (HA) is a natural emollient substance produced by the body, and it is found in highest concentrations in the joints, eyes, and skin. Unfortunately, as we age, the body produces less hyaluronic acid, resulting in everything from dry eyes and joint stiffness to fine lines and wrinkles on the face. Capable of biochemically holding up to 1,000 times its weight in water, hyaluronic acid can provide constant hydration to irritated or affected areas of the skin, reducing inflammation and itchiness. HA has seen a significant jump in popularity in recent years, as its efficacy in treating a broad range of dermatologic conditions has become well known around the world. 

A “Neu” Moisturizing Solution

The novel skin serum from NeuLuna, the Day and Night Cream is a twice-daily solution for persistent irritation and inflammation caused by seborrheic dermatitis. With hyaluronic acid as its primary active ingredient, supported by rosehip oil and oleyl erucate, the cream features a patented delivery system to improve transdermal penetration, boosting efficacy and outcomes. 

Providing a non-abrasive and skin-soothing option for patients suffering from both flareups and chronic symptoms of seborrheic dermatitis, NeuLuna's Day and Night Cream has been carefully engineered for targeted treatment. Visit our website today and take the first steps towards relieving your persistent and unpleasant SD symptoms.